Prademagene zamikeracel (Zevaskyn) is the first and only cell-based gene therapy for wound treatment in patients with ...

The FDA has approved Zevaskyn for the treatment of recessive dystrophic epidermolysis bullosa, the company announced in a ...

The condition, recessive dystrophic epidermolysis bullosa, causes chronic wounds and has an 84% mortality rate by age 40.

Patients with the debilitating dermatologic condition are born with COL7A1 mutations in both gene copies, affecting the ...

The best steroids for women are typically mild compounds like Anavar (Oxandrolone) and Winstrol (Stanozolol). These oral ...